Our Website Uses Cookies
We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.
For more information, please contact us or consult our Privacy Notice.
Your binder contains too many pages, the maximum is 40.
We are unable to add this page to your binder, please try again later.
This page has been added to your binder.
- Home
- News and Insights
- Insights
- The GDPR and Clinical Trials Are Study Sites Controllers or Processors
The GDPR and Clinical Trials – Are Study Sites Controllers or Processors?
June 2019, Pharmind
December 20, 2019, Covington Alert
On December 19, 2019, Advocate General (“AG”) Henrik Saugmandsgaard Øe handed down his Opinion in Case C-311/18, Data Protection Commissioner v Facebook Ireland and Maximillian Schrems (“Schrems II”). The AG’s Opinion provides non-binding guidance to the Court of Justice of the EU (“CJEU”) on how to decide the case.
July 17, 2019, Covington Alert
On July 9, 2019, the European Court of Justice (“ECJ”) heard oral argument in Case C-311/18, Data Protection Commissioner v Facebook Ireland and Maximillian Schrems (“Schrems II”). The primary question before the ECJ is whether the European Commission’s standard contractual clauses (“SCCs”) are valid for transfers of personal data to the United States.1 Given ...
December 21, 2015, Covington Alert
On December 15, the EU institutions finally agreed the text of the new EU data protection law, the General Data Protection Regulation (“GDPR”), completing a process that began in January 2012. The LIBE committee has published the consolidated version of the GDPR text. The GDPR heralds a new era of data protection. It replaces the existing data protection ...